IN2015MN00127A - - Google Patents

Info

Publication number
IN2015MN00127A
IN2015MN00127A IN127MUN2015A IN2015MN00127A IN 2015MN00127 A IN2015MN00127 A IN 2015MN00127A IN 127MUN2015 A IN127MUN2015 A IN 127MUN2015A IN 2015MN00127 A IN2015MN00127 A IN 2015MN00127A
Authority
IN
India
Prior art keywords
present
relates
composition
iron deficiency
solid composition
Prior art date
Application number
Other languages
English (en)
Inventor
Andrea Lacorte
Germano Tarantino
Original Assignee
Alesco Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alesco Srl filed Critical Alesco Srl
Publication of IN2015MN00127A publication Critical patent/IN2015MN00127A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
IN127MUN2015 2012-07-31 2013-07-30 IN2015MN00127A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001350A ITMI20121350A1 (it) 2012-07-31 2012-07-31 Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
PCT/IB2013/001659 WO2014009806A1 (fr) 2012-07-31 2013-07-30 Composition solide comprenant du fer destinée à être utilisée dans des conditions de carence en fer

Publications (1)

Publication Number Publication Date
IN2015MN00127A true IN2015MN00127A (fr) 2015-10-16

Family

ID=46982695

Family Applications (1)

Application Number Title Priority Date Filing Date
IN127MUN2015 IN2015MN00127A (fr) 2012-07-31 2013-07-30

Country Status (25)

Country Link
US (2) US10183077B2 (fr)
EP (2) EP2879667B1 (fr)
JP (1) JP6232426B2 (fr)
CN (2) CN104602674A (fr)
BR (2) BR112015002072B1 (fr)
CA (1) CA2879681C (fr)
CY (2) CY1121435T1 (fr)
DK (2) DK3498265T3 (fr)
EA (1) EA027684B1 (fr)
ES (2) ES2719252T3 (fr)
HR (2) HRP20190461T1 (fr)
HU (2) HUE052036T2 (fr)
IL (2) IL236793A0 (fr)
IN (1) IN2015MN00127A (fr)
IT (1) ITMI20121350A1 (fr)
LT (2) LT3498265T (fr)
MA (1) MA20150375A1 (fr)
ME (1) ME03349B (fr)
PL (2) PL2879667T3 (fr)
PT (2) PT2879667T (fr)
RS (2) RS58647B1 (fr)
SI (2) SI3498265T1 (fr)
SM (2) SMT202000671T1 (fr)
TR (1) TR201903899T4 (fr)
WO (1) WO2014009806A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20121350A1 (it) 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
ITMI20131483A1 (it) * 2013-09-09 2015-03-10 Alesco Srl Composizioni in forma solida a base di minerali e formulazioni orosolubili contenenti le stesse.
JP6299689B2 (ja) * 2014-07-24 2018-03-28 三生医薬株式会社 生体吸収促進剤含有組成物
JP6459129B2 (ja) * 2015-04-13 2019-01-30 富田製薬株式会社 ピロリン酸第二鉄含有粉末及びその製造方法
WO2017090198A1 (fr) * 2015-11-27 2017-06-01 太陽化学株式会社 Composition en poudre contenant du fer
IT201700085412A1 (it) * 2017-07-26 2019-01-26 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare
IT201700089258A1 (it) * 2017-08-02 2019-02-02 Pharmanutra S P A Composizione per uso nella prevenzione e nel trattamento di carenza di ferro
IT201800006288A1 (it) * 2018-06-13 2019-12-13 Composizioni comprendenti minerali sucrosomiali contenenti sali minerali per uso nelle condizioni di deficienza di tali minerali
IT201900007311A1 (it) 2019-05-27 2020-11-27 Alesco Srl Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati
IT201900007326A1 (it) 2019-05-27 2020-11-27 Alesco Srl Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari
IT201900020316A1 (it) 2019-11-04 2021-05-04 Alesco Srl Uso di berberina sucrosomiale® e sue composizioni nel trattamento di alterazioni del metabolismo glucidico
IT201900020300A1 (it) 2019-11-04 2021-05-04 Alesco Srl Uso di berberina sucrosomiale® e sue composizioni nel trattamento di dislipidemie
IT201900020290A1 (it) 2019-11-04 2021-05-04 Alesco Srl Berberina sucrosomiale®, sue composizioni e loro uso
IT201900021564A1 (it) * 2019-11-19 2021-05-19 Neilos S R L Composizione nutraceutica o farmaceutica comprendente ferro pirofosfato per l’uso nel trattamento e/o nella prevenzione di condizioni o patologie caratterizzate da carenza di ferro
IT201900022989A1 (it) 2019-12-04 2021-06-04 Alesco Srl Formulazione in forma solida di cromo, sue composizioni e usi
IT201900023016A1 (it) * 2019-12-04 2021-06-04 Alesco Srl Formulazioni comprendenti un minerale e un polisaccaride, loro composizioni e loro uso nella supplementazione di detto minerale
WO2022118274A1 (fr) * 2020-12-03 2022-06-09 Neilos S.r.l. Compositions destinées à être utilisées dans le traitement et/ou la prévention d'états ou de maladies de carence en fer
IT202100005981A1 (it) 2021-03-12 2022-09-12 Pharmanutra S P A Composizione a base di ferro per uso in un trattamento di una infiammazione gastrointestinale in soggetti sottoposti ad un trattamento di una deficienza di ferro
IT202100011084A1 (it) 2021-04-30 2022-10-30 Pharmanutra S P A Composizione nutraceutica per uso nel trattamento della stanchezza cronica/fatigue post covid-19
WO2023033750A1 (fr) * 2021-08-30 2023-03-09 Ilko Ilac Sanayi Ve Ticaret A.S. Formulation liquide sans conservateur de fer liposomal
IT202300001998A1 (it) 2023-02-07 2024-08-07 Pharmanutra S P A Nuove composizioni orali a base di ferro e gomma di acacia, procedimento per la loro preparazione e loro uso nelle condizioni di carenza di ferro
CN120957733A (zh) * 2023-02-07 2025-11-14 法尔曼特拉公司 新型铁和焦磷酸钠口服组合物、其制备方法及其在铁缺乏症中的用途
IT202300001989A1 (it) 2023-02-07 2024-08-07 Pharmanutra S P A Nuove composizioni orali a base di ferro e sodio pirofosfato, procedimento per la loro preparazione e loro uso nelle condizioni di carenza di ferro
IT202300001983A1 (it) 2023-02-07 2024-08-07 Pharmanutra S P A Nuove composizioni orali a base di ferro, procedimento per la loro preparazione e loro uso nelle condizioni di carenza di ferro
WO2026083282A2 (fr) 2024-10-15 2026-04-23 Pharmanutra S.P.A. Formulations comprenant au moins une vitamine et au moins un sel de phosphate, leurs compositions et leur utilisation dans la supplémentation en ladite au moins une vitamine

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0927025A4 (fr) 1996-09-18 2001-07-25 Dragoco Inc Composition de poudre seche contenant un principe actif encapsule dans des liposomes
DK0870435T3 (da) 1996-10-03 2004-05-24 Taiyo Kagaku Kk Mineralsammensætning
JP2000300213A (ja) * 1999-04-21 2000-10-31 Taiyo Kagaku Co Ltd ミネラル組成物及びミネラル強化飲食品
US6521247B1 (en) * 1999-08-13 2003-02-18 Warner Chilcott Laboratories Ireland Limited Dual iron containing nutritional supplement
JP2007224054A (ja) * 2004-02-02 2007-09-06 Taiyo Kagaku Co Ltd 鉄組成物
JP4627999B2 (ja) * 2004-02-27 2011-02-09 太陽化学株式会社 坑酸化剤
WO2005082167A1 (fr) * 2004-02-27 2005-09-09 Taiyo Kagaku Co., Ltd. Composition minérale et procédé d’utilisation de celle-ci
JP2006340612A (ja) * 2005-06-07 2006-12-21 Taiyo Kagaku Co Ltd ミネラル強化用組成物
JP2006340613A (ja) * 2005-06-07 2006-12-21 Taiyo Kagaku Co Ltd 鉄強化用組成物
WO2006137133A1 (fr) * 2005-06-22 2006-12-28 Taiyo Kagaku Co., Ltd. Composition enrichie en fer
CN102861336A (zh) * 2005-12-23 2013-01-09 阿贾伊·古普塔 含铁的肠胃外营养组合物
JP4673235B2 (ja) * 2006-02-16 2011-04-20 太陽化学株式会社 鉄強化食品用組成物
ES2395862T3 (es) * 2006-09-28 2013-02-15 Bayer Consumer Care Ag Mezcla de sales de hierro y de cobre para enmascarar el sabor metálico
WO2011156563A2 (fr) * 2010-06-09 2011-12-15 Emisphere Technologies, Inc. Thérapie orale de la carence en fer
US20120288531A1 (en) * 2011-01-14 2012-11-15 Shmuel Tuvia pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
ITMI20121350A1 (it) 2012-07-31 2014-02-01 Alesco Srl Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro.
US9594814B2 (en) 2012-09-07 2017-03-14 Splunk Inc. Advanced field extractor with modification of an extracted field

Also Published As

Publication number Publication date
IL265561A (en) 2019-05-30
CY1123610T1 (el) 2022-03-24
SI2879667T1 (sl) 2019-07-31
ES2830428T3 (es) 2021-06-03
EP2879667A1 (fr) 2015-06-10
EP3498265A1 (fr) 2019-06-19
ITMI20121350A1 (it) 2014-02-01
SMT202000671T1 (it) 2021-01-05
DK3498265T3 (da) 2020-11-16
US20150250885A1 (en) 2015-09-10
SMT201900221T1 (it) 2019-05-10
PT2879667T (pt) 2019-04-15
PT3498265T (pt) 2020-11-16
EP2879667B1 (fr) 2019-01-16
MA20150375A1 (fr) 2015-10-30
ME03349B (fr) 2019-10-20
HUE052036T2 (hu) 2021-04-28
HRP20201802T1 (hr) 2021-03-19
US20190105393A1 (en) 2019-04-11
IL265561B (en) 2021-02-28
LT3498265T (lt) 2021-01-25
US10183077B2 (en) 2019-01-22
CN111265546A (zh) 2020-06-12
BR122022015143B1 (pt) 2023-05-09
RS58647B1 (sr) 2019-05-31
PL3498265T3 (pl) 2021-03-08
LT2879667T (lt) 2019-05-10
CY1121435T1 (el) 2020-05-29
SI3498265T1 (sl) 2021-02-26
HRP20190461T1 (hr) 2019-06-14
ES2719252T3 (es) 2019-07-09
CA2879681C (fr) 2022-06-21
EA201590204A1 (ru) 2015-06-30
RS61069B1 (sr) 2020-12-31
JP6232426B2 (ja) 2017-11-15
TR201903899T4 (tr) 2019-04-22
US10765752B2 (en) 2020-09-08
IL236793A0 (en) 2015-03-31
CA2879681A1 (fr) 2014-01-16
EA027684B1 (ru) 2017-08-31
HUE042698T2 (hu) 2019-07-29
EP3498265B1 (fr) 2020-09-30
PL2879667T3 (pl) 2019-07-31
DK2879667T3 (en) 2019-04-15
BR112015002072B1 (pt) 2022-11-01
JP2015523409A (ja) 2015-08-13
WO2014009806A1 (fr) 2014-01-16
CN104602674A (zh) 2015-05-06
BR112015002072A2 (pt) 2017-07-04

Similar Documents

Publication Publication Date Title
EA201590204A1 (ru) Твердая композиция, содержащая железо, для применения при железодефицитных состояниях
SG11201707657UA (en) Methods and compositions relating to microbial treatment and diagnosis of skin disorders
JO3199B1 (ar) مركبات 5- فلورو-1h- بيرازولوبيريدينات مستبدلة واستخدامها
EP2925775A4 (fr) Compositions et méthodes de traitement de troubles et maladies métaboliques
IL237369A0 (en) Methods for treating Alzheimer's disease and pharmaceutical compositions thereof
TN2015000026A1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
IN2014MN02069A (fr)
PH12012501699A1 (en) Bisaryl-bonded aryltriazolones and use thereof
SG10201808102WA (en) Bicyclic heterocycle compounds and their uses in therapy
IN2012MN02591A (fr)
MY181828A (en) Bicyclically substituted uracils and the use therapy
IN2014DN08761A (fr)
PH12016500065A1 (en) Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof
IL233639A0 (en) Preparations and methods for the treatment of diseases and liver disorders
EP2897621A4 (fr) Composés et compositions pour une utilisation dans la prévention et le traitement de troubles associés à l'inflammation, de la douleur et de la fièvre, de troubles de la peau, du cancer et d'états précancéreux de celui-ci
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
MX2015008877A (es) Conjugados de disulfuro mixto de compuestos de tienopiridina y sus usos.
PH12016500608A1 (en) Cyclic thienouracil-carboxamides and use thereof
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
MX2013002261A (es) N-fenetiltriazolonacetamidas sustituidas y su uso.
MX2015005111A (es) Composicion a base de hierbas para la prevencion y tratamieto de tnf-a una enfermedad mediada.
SG10201706453XA (en) Herbal composition for treatment of gastrointestinal inflammatory diseases and method to prepare and use thereof
EP2855438A4 (fr) Nouveaux composés et nouvelles compositions pour le traitement de troubles ou de maladies du contrôle de la respiration
SG10201501606VA (en) Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders
TN2010000597A1 (en) Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof